B

Biolight Life Sciences Ltd
TASE:BOLT

Watchlist Manager
Biolight Life Sciences Ltd
TASE:BOLT
Watchlist
Price: 625 ILS 1.41% Market Closed
Market Cap: 27.4m ILS
Have any thoughts about
Biolight Life Sciences Ltd?
Write Note

Intrinsic Value

BOLT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BOLT stock under the Base Case scenario is 27.09 ILS. Compared to the current market price of 625 ILS, Biolight Life Sciences Ltd is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BOLT Intrinsic Value
27.09 ILS
Overvaluation 96%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Biolight Life Sciences Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BOLT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BOLT?
Bearish
Neutral
Bullish

Fundamental Analysis

Biolight Life Sciences Ltd
IL
Life Sciences Tools & Services
Market Cap
27.4m ILS
IPO
Dec 27, 2005
Employees
-
Israel
Market Cap
27.4m ILS
Industry
Life Sciences Tools & Services
IPO
Dec 27, 2005

BioLight Life Sciences Ltd. engages in the management, research and development, investments or sale of solutions, the purpose of which is to address a real need that exists in the field of eye diseases. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.

[ Read More ]

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Biolight Life Sciences Ltd

Provide an overview of the primary business activities
of Biolight Life Sciences Ltd.

What unique competitive advantages
does Biolight Life Sciences Ltd hold over its rivals?

What risks and challenges
does Biolight Life Sciences Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biolight Life Sciences Ltd.

Provide P/S
for Biolight Life Sciences Ltd.

Provide P/E
for Biolight Life Sciences Ltd.

Provide P/OCF
for Biolight Life Sciences Ltd.

Provide P/FCFE
for Biolight Life Sciences Ltd.

Provide P/B
for Biolight Life Sciences Ltd.

Provide EV/S
for Biolight Life Sciences Ltd.

Provide EV/GP
for Biolight Life Sciences Ltd.

Provide EV/EBITDA
for Biolight Life Sciences Ltd.

Provide EV/EBIT
for Biolight Life Sciences Ltd.

Provide EV/OCF
for Biolight Life Sciences Ltd.

Provide EV/FCFF
for Biolight Life Sciences Ltd.

Provide EV/IC
for Biolight Life Sciences Ltd.

Show me price targets
for Biolight Life Sciences Ltd made by professional analysts.

What are the Revenue projections
for Biolight Life Sciences Ltd?

How accurate were the past Revenue estimates
for Biolight Life Sciences Ltd?

What are the Net Income projections
for Biolight Life Sciences Ltd?

How accurate were the past Net Income estimates
for Biolight Life Sciences Ltd?

What are the EPS projections
for Biolight Life Sciences Ltd?

How accurate were the past EPS estimates
for Biolight Life Sciences Ltd?

What are the EBIT projections
for Biolight Life Sciences Ltd?

How accurate were the past EBIT estimates
for Biolight Life Sciences Ltd?

Compare the revenue forecasts
for Biolight Life Sciences Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biolight Life Sciences Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biolight Life Sciences Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biolight Life Sciences Ltd compared to its peers.

Compare the P/E ratios
of Biolight Life Sciences Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Biolight Life Sciences Ltd with its peers.

Analyze the financial leverage
of Biolight Life Sciences Ltd compared to its main competitors.

Show all profitability ratios
for Biolight Life Sciences Ltd.

Provide ROE
for Biolight Life Sciences Ltd.

Provide ROA
for Biolight Life Sciences Ltd.

Provide ROIC
for Biolight Life Sciences Ltd.

Provide ROCE
for Biolight Life Sciences Ltd.

Provide Gross Margin
for Biolight Life Sciences Ltd.

Provide Operating Margin
for Biolight Life Sciences Ltd.

Provide Net Margin
for Biolight Life Sciences Ltd.

Provide FCF Margin
for Biolight Life Sciences Ltd.

Show all solvency ratios
for Biolight Life Sciences Ltd.

Provide D/E Ratio
for Biolight Life Sciences Ltd.

Provide D/A Ratio
for Biolight Life Sciences Ltd.

Provide Interest Coverage Ratio
for Biolight Life Sciences Ltd.

Provide Altman Z-Score Ratio
for Biolight Life Sciences Ltd.

Provide Quick Ratio
for Biolight Life Sciences Ltd.

Provide Current Ratio
for Biolight Life Sciences Ltd.

Provide Cash Ratio
for Biolight Life Sciences Ltd.

What is the historical Revenue growth
over the last 5 years for Biolight Life Sciences Ltd?

What is the historical Net Income growth
over the last 5 years for Biolight Life Sciences Ltd?

What is the current Free Cash Flow
of Biolight Life Sciences Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biolight Life Sciences Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biolight Life Sciences Ltd

Current Assets 14.1m
Cash & Short-Term Investments 4.5m
Receivables 659k
Other Current Assets 8.9m
Non-Current Assets 21.7m
Long-Term Investments 16.3m
PP&E 4.4m
Intangibles 686k
Other Non-Current Assets 251k
Current Liabilities 3.2m
Accounts Payable 2.7m
Other Current Liabilities 533k
Non-Current Liabilities 1.4m
Long-Term Debt 313k
Other Non-Current Liabilities 1m
Efficiency

Earnings Waterfall
Biolight Life Sciences Ltd

Revenue
198k ILS
Operating Expenses
-10.2m ILS
Operating Income
-10m ILS
Other Expenses
3.8m ILS
Net Income
-6.2m ILS

Free Cash Flow Analysis
Biolight Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BOLT Profitability Score
Profitability Due Diligence

Biolight Life Sciences Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROIC is Increasing
Exceptional 1-Year Revenue Growth
Declining ROE
28/100
Profitability
Score

Biolight Life Sciences Ltd's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

BOLT Solvency Score
Solvency Due Diligence

Biolight Life Sciences Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
67/100
Solvency
Score

Biolight Life Sciences Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BOLT Price Targets Summary
Biolight Life Sciences Ltd

There are no price targets for BOLT.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BOLT?

Click here to dive deeper.

Dividends

Biolight Life Sciences Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for BOLT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one BOLT stock?

The intrinsic value of one BOLT stock under the Base Case scenario is 27.09 ILS.

Is BOLT stock undervalued or overvalued?

Compared to the current market price of 625 ILS, Biolight Life Sciences Ltd is Overvalued by 96%.

Back to Top